SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-001525
Filing Date
2023-03-15
Accepted
2023-03-15 17:24:43
Documents
13
Period of Report
2023-03-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT avid_8k.htm   iXBRL 8-K 33073
2 CREDIT AGREEMENT DATED AS OF MARCH 14, 2023 avid_ex1001.htm EX-10.1 1045389
  Complete submission text file 0001683168-23-001525.txt   1469901

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cdmo-20230314.xsd EX-101.SCH 3224
4 XBRL LABEL FILE cdmo-20230314_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cdmo-20230314_pre.xml EX-101.PRE 22357
7 EXTRACTED XBRL INSTANCE DOCUMENT avid_8k_htm.xml XML 3484
Mailing Address 14191 MYFORD ROAD TUSTIN CA 92780
Business Address 14191 MYFORD ROAD TUSTIN CA 92780 714.508.6100
Avid Bioservices, Inc. (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-32839 | Film No.: 23736263
SIC: 2834 Pharmaceutical Preparations